Börsipäev 9. veebruar
Postitusi kokku 6
Erko_Rebane

Turuosalised on novembrist väldanud tõusu järel jäänud äraootavale seisukohale, otsides võrdlemisi kõrgetele valuatsioonidele järgmist õigustust, samal ajal takistades hindadel ka sügavamasse miinusesse vajumast. Eilset päeva alustas S&amp;P 500 finants- ja energiasektori eestvedamisel -0,3% langusega, kuid ostjad aitasid juba enne keskpäeva indeksil tagasi plussi ronida, lõpetades sessiooni 0,1% võiduga.<br/><br/> Ka Euroopas jäid liikumised võrdlemisi marginaalseks, kuid Stoxx 600 0,3% paranemine märkis siiski teist järjestikust tõusupäeva. Plusspoolel paistsid silma Firstgroup +4.8%, Neste +4.8%, Vinci +4.7%, Orpea +4.6%, SES +4.6%, suurima langusega pidid leppima Tullow Oil -5.4%,H Lundbeck -5.1%, AP Moller - Maersk -5.0%, Petrofac -4.6%, Victrex -4.1%.<br/><br/>Selget suunda ei näidanud aktsiaturud öösel ka Aasias, kus tugevamalt esinenud Hiina, Hongkongi ja Austraalia börsiindeksite kõrval sulgus Nikkei -0,5% madalamal, seda hoolimata oodatust paremast Jaapani masinate tellimustest. Viimased taastusid pärast novembrikuu -5,1% langust MoM 6,7% (prognoositi 3,0%), saavutades aastatagusega võrreldes samuti 6,7% kasvu. Kuigi tegemist on volatiilse näitajaga, võiks tellimuste kasv viidata ettevõtete hoogsamale kapitaliinvesteeringutele, mille jätkumist prognoosivad ettevõtted ka esimeses kvartalis. <br/><br/><img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/3X/f/8/f8afe8568eb557bec118ebc123c5424eb3972f7b.png"/><br/><br/>Tänastes majandusuudistes langeb tähelepanu Ühendriikide möödunud nädala esmastele töötu abiraha taotlustele ning FEDi presidentide James Bullardi ning Charles Evansi (FOMC hääletav liige) kõnedele. <br/><br/>09.00 Saksamaa kaubavahetuse statistika (detsember)<br/>09.00 Norra neljanda kvartali SKP<br/>10.30 Rootsi majade keskmine hind (jaanuar)<br/>15.30 USA esmased töötu abiraha taotlused <br/>16.05 FEDi Bullard esineb <br/>17.00 USA hulgimüük ja varud (detsember)<br/>20.10 FEDi Evans esineb <br/><img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/3X/4/f/4fb52b6144f4dd4515288e61affe0a29be52cfd1.png"/>

Erko_Rebane

JPMorgan toob välja, et isegi kui Le Pen võidab presidendivalimised, siis puudub tal piisav poolehoid parlamendis ja see muudab teekonna võimaliku referendumini keerulisemaks<br/><br/><i> Bank believes the probability that Le Pen wins the presidential election is low (14% chance)<br/> A victory at the presidential election is only one step toward full powers as the president also needs a majority in parliament<br/> The likelihood Le Pen obtains a majority in parliament is low and a period of cohabitation would be likely if she wins the presidential election<br/> Le Pen wouldn’t be able to choose the prime minister, who would be in charge of the domestic agenda and strongly influence the external agenda<br/> A period of cohabitation would make any referendum difficult to achieve<br/> A constitutional change normally means invoking article 89 of the constitution and first requires a vote in the<br/> lower and upper houses; article 11 could be used to avoid such hurdle, but the conditions to trigger a referendum under Article 11 are also strict</i>

Erko_Rebane

Rootsi majade keskmine hind kallines jaanuaris aastaga 3,2% rekordilise 2,916 miljoni Rootsi kroonini (detsembris YoY 8,4%, novembris 8,9%)<br/><img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/3X/e/0/e0cb869484a145c377c3d6ad217fcca2efad200f.png"/>

Erko_Rebane

Sentimendi uuringud Ühendriikides peegeldavad küllaltki erinevat pilti investeerimisnõustajate ja väikeaktsionäride seas. Kui esimeste seas on küsitluse järgi pullide osakaal kõrgeim alates 2004.a...<br/><img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/3X/1/0/102864e7540923ea0a54825ffbd27f63a5010f0c.png"/><br/><br/>...siis väikeinvestorite seas nõnda eurofooriline meeleolu pole (pullide osakaal kerkis läinud nädalal 33% pealt 36%le, karude osakaal alanes 34% pealt 28%le ning neutraalsete osakaal suurenes 33% pealt 37%le).<br/><img src="//fp-live-discourse-bucket.s3.dualstack.eu-north-1.amazonaws.com/original/3X/a/5/a5fc5db4e6b736e3022ab9340fee79031604bbc3.png"/>

Erko_Rebane

USA töötu abiraha taotlused madalaimad viimase 44a jooksul<br/><br/><i>US Initial Jobless Claims (WoW, 4/Feb): 234k (est 249k, prev 246k)<br/>US Initial Jobless Claims 4wk Avg (WoW, 4/Feb): 244.25k (prev 248k)</i>

Nelli_Janson

<b>Gapping up <br/>In reaction to strong earnings/guidance:</b><br/>SKYS +65.8%, (thinly traded), OSUR +23.4%, AVNW +15.9%, (thinly traded), TZOO +11.6%, PAYC +11%, ZEN +10.1%, MPAA +9.8%, CLF +9.8%, PCMI +9.5%<br/>IMPV +9.3%, (also agrees to sell its Skyfence technology and service to Forcepoint, financial details not disclosed; acquires the assets of Camouflage Software)<br/>WSTL +8.4%, FLT +7.8%, PRLB +6.5%, SCSS +6.2%, MDSO +6.1%, LLNW +5.4%, CXW +5.2%, LIVE +4.4%, ARRY +3.5%, ALNY +3.4%, RLGT +3.4%<br/>VIA +3%, CMP +2.9%, FONR +2.7%, AOSL +2.5%, GPRE +2.2%, CVS +2.2%, MFC +2%, EFX +1.9%, TU +1.9%, CETX +1.9%, FORM +1.6%, CMI +1.6%<br/>PTN +1.4%, WWE +1.4%, BGCP +1.3%, ROP +1.2%, RAI +1.1%, PSEC +1%, TOT +1%, RMR +0.9%, OHI +0.8%, CRAY +0.8%, AFG +0.7%, YUM +0.6%, PRU +0.5%<br/><b>M&amp;A news:</b><br/>JAGX +69% (Jaguar Animal Health to merge with Napo Pharmaceuticals)<br/>NOK +1.4% (to acquire Comptel for EUR 347 mln)<br/><b>Other news:</b><br/>ETRM +17.8% (publication of three-year data from the Company&#39;s VBLOC DM2 Study of vBloc Neurometabolic Therapy)<br/>AQMS +16.1% (announces that Johnson Controls (JCI) finalized an agreement covering North America, China and Europe for its technology)<br/>RELV +14.7% (thinly traded; announced that CardioSentials heart health supplement has earned a U.S. patent)<br/>ACOR +12.3% (announces &#39;positive&#39; Phase 3 data of CVT-301 &#39;showing a statistically significant improvement in motor function in people with Parkinson&#39;s disease experiencing OFF periods)<br/>VKTX +11.7% (announces &#39;positive&#39; initial results from a proof-of-concept study of VK2809)<br/>PPHM +9.9% (announces the publication of positive proof-of-concept data for a novel exosome-based cancer detection platform)<br/>BANC +5.6% (Banc of California appoints Richard Lashley, co-founder of 6.9% holder PL Capital Advisors, to the Board and approves certain enhancements to corporate governance policies)<br/>URRE +3.8% (announces its Special meeting not convened, nor adjourned to later date; RCF debt to be repaid from treasury)<br/>STB +3.2% ( awarded new record $187 million contract )<br/>SNY +2.3% (Regeneron Pharma confirms appeals court grants stay of permanent injunction for Praluent (alirocumab) during appeals process)<br/>TSLA +2.1% (Reuters details that Tesla (TSLA) plans to pause factory production in California to prepare for Model 3)<br/>XGTI +2.1% (prices offering of 1.75 mln shares of common stocks and warrants of up to 1.3 mln shares at $2.00 per share)<br/>ETP +1.7% (received US Army Corps of Engineers easement to construct N Dakota pipeline (as expected - see Feb 7 comments); Dakota Access has now received all federal authorizations necessary to proceed)<br/>BP +1.1% (in sympathy with TOT earnings)<br/>RDS.A +1.1% (in sympathy with TOT earnings)<br/>DECK +0.9% (following late move higher on Marcato active stake disclosure)<br/>BA +0.8% (confirms that Singapore Airlines has commited to purchase 20 777-9s and 19 787-10 Dreamliners)<br/><b>Analyst comments:</b><br/>RMBS +2.8% (upgraded to Overweight from Neutral at JP Morgan)<br/>FNV +0.7% (upgraded to Neutral from Sell at Goldman)<br/>ALV +0.6% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)<br/><br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance:</b><br/>SNCR -15.9%, LPSN -15.2%, FSC -13.4%, MTRX -10.6%, MB -10.5%, QLYS -9.1%, TWTR -8.9%, IRBT -8.8%, BGC -8%, VSTO -7.6%, SON -7.5%, OII -7%<br/>MXL -6.9%, LQDT -6.8%, GLUU -6%, STRL -5.8%, (sees Q4 net loss of $5.5-6.5 mln and revs of $165-170 mln vs. $157.25 mln two analyst estimate; says results are &#39;very disappointing&#39;)<br/>ECHO -5.3%, COTY -5.2%, ENSG -5%, TYL -4.8%, CDE -4.2%, TBI -3.6%, KS -3.4%, ENTA -3.3%, UHAL -3%, MC -3%, SNN -2.9%, FSFR -2.8%, FISV -2.6%<br/>PPC -2.1%, KO -2.1%, GLAD -1.7%, AGTC -1.5%, MAS -1.5%, CTL -1.4%, PDS -1.3%, DTE -1.2%, REGN -1.2%, JE -1%, CX -0.6%, SEE -0.5%<br/><b>Other news:</b><br/>SRRA -9.1% (to offer shares of its common stock in an underwritten public offering; size not disclosed)<br/>CREE -5.5% (CFIUS informed Infineon and Cree that the Wolfspeed transaction poses a risk to the national security of the United States)<br/>AMGN -1.4%/ REGN -1.2% (Regeneron Pharma confirms appeals court grants stay of permanent injunction for Praluent (alirocumab) during appeals process)<br/>TM -1.2% (traded ~2% lower in Japan overnight)<br/>HLI -1.1% (prices offering of 8 mln shares of common stock by co and selling shareholders at $29.25 per share)<br/>FSLR -1% (awarded module supply contract for the 140 megawatt DC Sun Metals Solar Farm in North Queensland)<br/>PYPL -0.9% (discloses that it has received subpoenas from the DOJ seeking the production of certain information related to the company&#39;s historical anti-money laundering program)<br/>KR -0.9% (WFM sympathy)<br/><b>Analyst comments:</b><br/>SLW -1% (downgraded to Neutral from Buy at Goldman)<br/>FCX -1% (resumed with a Neutral at JP Morgan)<br/><br/>Briefing.com